• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Progesterone levels on the hCG day and outcomes in vitro fertilization in women with polycystic ovary syndrome.人绒毛膜促性腺激素日子宫内膜厚度及孕激素水平与多囊卵巢综合征患者体外受精结局的关系。
J Assist Reprod Genet. 2012 Jul;29(7):603-7. doi: 10.1007/s10815-012-9762-6. Epub 2012 May 3.
2
Premature luteinization and in vitro fertilization outcome in gonadotropin/gonadotropin-releasing hormone antagonist cycles in women with polycystic ovary syndrome.多囊卵巢综合征女性在促性腺激素/促性腺激素释放激素拮抗剂周期中的过早黄素化与体外受精结局
Fertil Steril. 2009 May;91(5):1755-9. doi: 10.1016/j.fertnstert.2008.02.009. Epub 2008 Apr 3.
3
Gonadotropin releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome.促性腺激素释放激素拮抗剂在多囊卵巢综合征女性的控制性卵巢刺激和宫腔内人工授精周期中的应用
Taiwan J Obstet Gynecol. 2019 Mar;58(2):234-238. doi: 10.1016/j.tjog.2019.01.012.
4
Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.多囊卵巢综合征患者中采用灵活 GnRH 拮抗剂方案与孕激素预刺激卵巢刺激(PPOS)方案:临床结局和卵巢反应的比较。
Curr Med Sci. 2019 Jun;39(3):431-436. doi: 10.1007/s11596-019-2055-x. Epub 2019 Jun 17.
5
A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles.多囊卵巢综合征患者与单纯超声多囊卵巢患者在 GnRH 拮抗剂周期中体外受精结局的比较研究。
Arch Gynecol Obstet. 2010 Aug;282(2):199-205. doi: 10.1007/s00404-010-1401-9. Epub 2010 Feb 25.
6
In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?多囊卵巢综合征女性卵母细胞体外成熟与促性腺激素释放激素拮抗剂体外受精的比较:能否确定优势?
Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:46-50. doi: 10.1016/j.ejogrb.2014.05.013. Epub 2014 Jun 2.
7
In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.多囊卵巢综合征女性体外成熟与使用促性腺激素释放激素拮抗剂的体外受精:治疗结局及卵巢过度刺激综合征发生率
Reprod Biomed Online. 2014 Nov;29(5):545-51. doi: 10.1016/j.rbmo.2014.07.019. Epub 2014 Aug 12.
8
Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome.促性腺激素释放激素拮抗剂周期中的过早黄素化及其与体外受精结局的关系。
Fertil Steril. 2003 Dec;80(6):1444-9. doi: 10.1016/j.fertnstert.2003.07.002.
9
[Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].[血脂异常对多囊卵巢综合征患者体外受精/卵胞浆内单精子注射妊娠结局的影响]
Zhonghua Fu Chan Ke Za Zhi. 2018 Jun 25;53(6):402-408. doi: 10.3760/cma.j.issn.0529-567x.2018.06.008.
10
Increased progesterone/estradiol ratio on the day of HCG administration adversely affects success of in vitro fertilization-embryo transfer in patients stimulated with gonadotropin-releasing hormone agonist and recombinant follicle-stimulating hormone.在给予人绒毛膜促性腺激素当天,孕酮/雌二醇比值升高对接受促性腺激素释放激素激动剂和重组促卵泡生成素刺激的患者体外受精-胚胎移植的成功率有不利影响。
Taiwan J Obstet Gynecol. 2008 Jun;47(2):168-74. doi: 10.1016/S1028-4559(08)60075-3.

引用本文的文献

1
Progesterone level in assisted reproductive technology: a systematic review and meta-analysis.辅助生殖技术中的孕酮水平:一项系统评价和荟萃分析。
Sci Rep. 2024 Dec 28;14(1):30826. doi: 10.1038/s41598-024-81539-z.
2
Pre-Ovulatory Hormones on Day of Human Chorionic Gonadotropin Trigger and Assisted Reproductive Technique Outcomes in Different Ovarian Response Groups.人绒毛膜促性腺激素触发日的排卵前激素与不同卵巢反应组的辅助生殖技术结局
J Hum Reprod Sci. 2021 Oct-Dec;14(4):406-414. doi: 10.4103/jhrs.jhrs_91_21. Epub 2021 Dec 31.
3
The curious case of premature luteinization.早发性黄体化的奇特案例。
J Assist Reprod Genet. 2018 Oct;35(10):1723-1740. doi: 10.1007/s10815-018-1264-8. Epub 2018 Jul 26.

本文引用的文献

1
The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria.基于不同诊断标准的伊朗妇女多囊卵巢综合征的患病率。
Endokrynol Pol. 2011;62(3):238-42.
2
Progesterone rise on the day of HCG administration (premature luteinization) in IVF: an overdue update.HCG 注射日孕激素升高(黄体过早化):IVF 中逾期未更新的问题。
J Assist Reprod Genet. 2010 Apr;27(4):149-55. doi: 10.1007/s10815-010-9393-8. Epub 2010 Feb 23.
3
Insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age < or =14 years, 13 with precocious puberty, 23 with a first-degree relative with polycystic ovary syndrome.25名年龄小于或等于14岁的青春期前女孩中的胰岛素抵抗、肥胖、纤维蛋白溶解功能减退、高雄激素血症及冠心病危险因素,其中13名性早熟,23名有一位患多囊卵巢综合征的一级亲属。
J Pediatr Endocrinol Metab. 2008 Oct;21(10):973-84. doi: 10.1515/JPEM.2008.21.10.973.
4
Serum progesterone concentration on day of HCG administration and IVF outcome.注射人绒毛膜促性腺激素当天的血清孕酮浓度与体外受精结局
Reprod Biomed Online. 2008 May;16(5):627-31. doi: 10.1016/s1472-6483(10)60475-0.
5
Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer.人绒毛膜促性腺激素给药当天孕酮升高会损害第3天单胚胎移植的妊娠结局,而对第5天单囊胚移植没有影响。
Fertil Steril. 2009 Mar;91(3):949-52. doi: 10.1016/j.fertnstert.2006.12.064. Epub 2007 Jun 6.
6
Precycle administration of GnRH antagonist and microdose HCG decreases clinical pregnancy rates without affecting embryo quality and blastulation.GnRH拮抗剂与微剂量人绒毛膜促性腺激素的预周期给药会降低临床妊娠率,且不影响胚胎质量和囊胚形成。
Reprod Biomed Online. 2006 Oct;13(4):465-75. doi: 10.1016/s1472-6483(10)60632-3.
7
PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.根据鹿特丹共识标准的多囊卵巢综合征:世界卫生组织Ⅱ型无排卵患病率的变化及其与代谢因素的关联。
BJOG. 2006 Oct;113(10):1210-7. doi: 10.1111/j.1471-0528.2006.01008.x.
8
The significance of premature luteinization in an oocyte-donation programme.过早黄素化在卵母细胞捐赠计划中的意义。
Hum Reprod. 2006 Jun;21(6):1503-7. doi: 10.1093/humrep/dei474. Epub 2006 Apr 28.
9
Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles.人绒毛膜促性腺激素(HCG)给药当天的血清孕酮浓度无法预测辅助生殖周期中的妊娠情况。
Reprod Biomed Online. 2004 Feb;8(2):183-90. doi: 10.1016/s1472-6483(10)60514-7.
10
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).2003年修订的关于多囊卵巢综合征(PCOS)的诊断标准及长期健康风险的共识。
Hum Reprod. 2004 Jan;19(1):41-7. doi: 10.1093/humrep/deh098.

人绒毛膜促性腺激素日子宫内膜厚度及孕激素水平与多囊卵巢综合征患者体外受精结局的关系。

Progesterone levels on the hCG day and outcomes in vitro fertilization in women with polycystic ovary syndrome.

机构信息

Department of Pharmacy and Life Science, University of South China, Hengyang, 421001, People's Republic of China.

出版信息

J Assist Reprod Genet. 2012 Jul;29(7):603-7. doi: 10.1007/s10815-012-9762-6. Epub 2012 May 3.

DOI:10.1007/s10815-012-9762-6
PMID:22552733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3401251/
Abstract

BACKGROUND

The purpose of this study was to determine the incidence of premature luteinization in patients with polycystic ovary syndrome and compared the main determinants of success in in-vitro fertilization in PCOS patients with and without premature luteinization.

METHODS

Retrospective analysis of 180 PCOS women of Chinese Han origin with infertility who underwent controlled ovarian hyperstimulation (COH) with an exogenous gonadotropin/GnRH antagonist protocol. Hormone levels on the hCG day and IVF outcomes were assessed.

RESULTS

The incidence of premature luteinization was 23.3 %. Compared with PCOS patients without premature luteinization, PCOS patients with premature luteinization(PL) had a higher number of oocytes retrieved (18.20 ± 6.6 vs 15.08 ± 7.3, p = 0.037) and a higher fertilization rate (72.9 ± 1.9 vs63.1 ± 2.3, p = 0.033), but clinical pregnancy rates were no statistical significance (53.3 vs 56.0, p = 0.836). Though the implantation rate was higher in no premature luteinization patients, but the difference was not statistically significant (37.7 vs 30.3, p = 0.115).

CONCLUSION

The PCOS patients with premature luteinization had a higher fertilization rate and high number of oocytes retrieved, and the similar implantation rate and clinical PRs as PCOS patients without premature luteinization.

摘要

背景

本研究旨在确定多囊卵巢综合征(PCOS)患者中黄体过早出现的发生率,并比较黄体过早出现与无黄体过早出现的 PCOS 患者体外受精(IVF)成功的主要决定因素。

方法

回顾性分析了 180 例患有不孕症的汉族 PCOS 女性,她们接受了外源性促性腺激素/GnRH 拮抗剂方案的控制性卵巢超刺激(COH)。评估了 hCG 日的激素水平和 IVF 结局。

结果

黄体过早出现的发生率为 23.3%。与无黄体过早出现的 PCOS 患者相比,黄体过早出现(PL)的 PCOS 患者获得的卵母细胞数更多(18.20±6.6 对 15.08±7.3,p=0.037),受精率更高(72.9±1.9 对 63.1±2.3,p=0.033),但临床妊娠率无统计学意义(53.3 对 56.0,p=0.836)。尽管黄体过早出现的患者着床率较高,但差异无统计学意义(37.7 对 30.3,p=0.115)。

结论

黄体过早出现的 PCOS 患者受精率较高,获得的卵母细胞数较多,与无黄体过早出现的 PCOS 患者相比,着床率和临床妊娠率相似。